Global Cardiology Surgery, Devices and Drugs Market Research and Forecast, 2018-2023

Cardiology devices & drugs market is expected to grow at a CAGR of 7.4% for the forecasted period of 2018-2023. The report covers three major segments of interventional cardiology market which include surgeries, devices, and drugs. As per WHO more than 17 million people died due to CVD in 2015 which makes is the number one cause of death globally. Some of the major CVDs include coronary heart diseases, stroke, hypertensive heart diseases, inflammatory heart diseases, rheumatoid heart diseases and others. Coronary heart diseases are the leading cause of death followed by strokes. The prevalence and incidence rate of heart diseases are on a rise; especially in major emerging countries such as India, China, and Japan. The market of cardiology surgery, devices and drugs are also on a rise.

One of the major factors driving the market is medical tourism. Especially in emerging markets such as India, ASEAN countries and China, the cost of surgery and treatment for cardiovascular diseases is low. In India, a heart surgery costs around $1,500 whereas in the United States it costs 5 to 10 times more than India. Hence, many Americans prefer to travel to India for their treatment.

North America is the leading market with highest market share. The market is expected to grow at a CAGR of 6.8 percent. North American marker is followed by Europe, Asia-Pacific and Rest of the world. Asia Pacific market is expected to have highest CAGR of 9.5% for the forecasted period of 2018-2023.

Key companies profiled in the report includes Pfizer, Sanofi, AstraZeneca, Novartis, Bristol-Myers Squibb, Merck, Boston Scientific Corp., Medtronic, Sun Pharma, Roche Bayer and others.

Some Brief Table of Contents of Report

CHAPTER 1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN

CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. GAP ANALYSIS
2.2. ANALYST & CURRENT MARKET TRENDS
2.3. REGULATIONS
2.4. TYPE OF CARDIOVASCULAR DISEASES

CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.2. RESTRAINTS
3.3. OPPORTUNITIES

CHAPTER 4. MARKET SEGMENTATION
4.1. BY CARDIOLOGY DEVICES TYPES
4.2. BY CARDIOLOGY DRUGS TYPES
4.3. BY CARDIOLOGY DRUGS BY MECHANISM
4.4. BY CARDIOLOGY SURGERIES TYPES

TOC Continued....

Browse full report at: https://www.omrglobal.com/industry-reports/cardiology-surgery-devices-drugs-market/

Related Reports: https://www.omrglobal.com/reports-category/medical-devices/

For More Updates Follow LinkedIn: www.linkedin.com/company/omr-global-research/

About Orion Market Research

“OMR is a market research company known for its qualitative and quantitative research reports. The company aims to provide business insights for decision making to our global clients. OMR provides syndicated and customized research reports, company profiling, consulting and other research-based services to global clients. At OMR, we believe in overcoming the competition by delivering quality reports on time. The “Orion” in our name signifies rising up in the sky, we are committed to providing valuable insights that will help you rise and shine. We follow our core values to achieve the aim of providing best solution and satisfaction to our clients by maintaining quality reports in stipulated time. OMR provide customer-centric reports which facilitate our subscribers to know their touch points which can be capitalized for their revenue growth and to gain a competitive edge. Our thorough analysis starts right from grass root level where in we extend lens not only to our clients but also to the customer of our clients, this exclusiveness helps our subscribers in effective decision making and to improve business strategy.”

CORPORATE OFFICE:

Orion Market Research Pvt Ltd
116, Shagun Arcade, Vijay Nagar Square
Indore – India- 452010
Email: info@omrglobal.com, support@omrglobal.com
India: +91-780-304-0404, +91-917-982-8694
Global: +1-646-755-7667

This release was published on openPR.